February 06, 2026

Baptist Health Miami Cancer Institute Names Bruna Pellini, M.D., Chief of Thoracic Medical Oncology

Board-certified thoracic oncologist Bruna Pellini, M.D., has been named chief of thoracic medical oncology at Baptist Health Miami Cancer Institute.

Baptist Health South Florida

February 06, 2026

World Cancer Day: Taking a Proactive Approach to the Most Commonly Diagnosed Cancer

On World Cancer Day, marked annually on February 4, it’s important to note that skin cancer is the most frequently diagnosed cancer. One in every five Americans will experience some form of skin cancer by age 70, experts say.

Baptist Health South Florida

January 31, 2026

Case Study: ICU-Based Chemotherapy for High-Risk Cardiac DLBCL Patient

A 34-year-old woman with newly diagnosed mediastinal diffuse large B-cell lymphoma developed alarming cardiac symptoms during her initial hospitalization.

Temple Health

January 29, 2026

Can a BiTE Immunotherapy Improve Survival in Young Patients with High-Risk Kinase-Driven B-ALL Subtypes?

Two genetic subtypes of childhood B-cell acute lymphoblastic leukemia (B-ALL) have long been associated with inferior treatment outcomes: Philadelphia chromosome-positive (Ph+) and ABL-class Philadelphia chromosome-like (Ph-like) B-ALL.

Roswell Park Comprehensive Cancer Center

January 28, 2026

Perioperative Pembrolizumab Plus Surgery and Risk-Adapted Standard Adjuvant Therapy Shows Benefit in Locally Advanced Head and Neck Cancer

Earlier this year, the first interim analysis of the phase III KEYNOTE-689 trial showed that the use of the PD-1 inhibitor pembrolizumab as part of a perioperative treatment regimen with standard-of-c...

The ASCO Post

January 27, 2026

Chronic Toxicity Rates With De-escalated vs Standard Adjuvant Radiotherapy in HPV-Associated Oropharyngeal Squamous Cell Carcinoma

In a U.S. two-center phase III trial (MC1675) reported in The Lancet Oncology, Ma et al found that de-escalated adjuvant radiotherapy was associated with a reduced cumulative, chronic grade ≥ 3 toxici...

The ASCO Post

January 22, 2026

Could Opportunistic Salpingectomy Prevent Ovarian Cancer in Postreproductive Women?

At the American College of Surgeons Clinical Congress 2025, a session on integrating fallopian tube removal into general surgery practice explored the need for greater awareness of offering the proced...

The ASCO Post

January 22, 2026

Investigating the Mechanisms of Cardiovascular Adverse Events Linked to Certain Cancer Treatments

The true upside of the many advances in cancer treatment is clear. Approximately 18.6 million people in the United States have a history of cancer, and the number of cancer survivors is expected to ex...

The ASCO Post

January 21, 2026

KEYNOTE-905: Perioperative Immunotherapy Regimen Active in Cisplatin-Ineligible MIBC

A perioperative regimen of enfortumab vedotin-ejfv plus pembrolizumab significantly improved survival and pathologic complete response rates compared to radical cystectomy alone in patients with muscl...

The ASCO Post